Sandbox: DDx 2: Difference between revisions
No edit summary |
(→DDX 2) |
||
(One intermediate revision by the same user not shown) | |||
Line 89: | Line 89: | ||
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Symptoms'''}} | ! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Symptoms'''}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Diaphoresis''' | '''Diaphoresis''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 98: | Line 98: | ||
Absent | Absent | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Watery diarrhea''' | '''Watery diarrhea''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 107: | Line 107: | ||
Absent | Absent | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Heartburn''' | '''Heartburn''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 118: | Line 118: | ||
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Lab values'''}} | ! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Lab values'''}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Hypoglycemia''' | '''Hypoglycemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 127: | Line 127: | ||
Absent | Absent | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Hypokalemia''' | '''Hypokalemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 136: | Line 136: | ||
Absent | Absent | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | ||
'''Hypergastrinemia''' | '''Hypergastrinemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Line 145: | Line 145: | ||
Present | Present | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | ! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Imaging'''}} | ||
'''CT | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | |||
'''CT Scan''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Calcification and hyperattenuation of the mass | Calcification and hyperattenuation of the mass | ||
Line 153: | Line 155: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align=center| | ||
Small hypoattenuating nodule ± calcification | Small hypoattenuating nodule ± calcification | ||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center| | |||
'''MRI''' | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
T2-weighted, increased-signal intensity mass | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
T1-weighted, decreased-signal-intensity masses | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | |||
T1-weighted, decreased-signal intensity masses | |||
|- | |- | ||
| style="padding: 5px 5px; background: #8f8990; font-weight: bold" align=center |{{fontcolor|#FFF| | | style="padding: 5px 5px; background: #8f8990; font-weight: bold" align=center |{{fontcolor|#FFF| |
Latest revision as of 02:12, 22 October 2015
DDX 1
Differential Diagnosis | Key Symptoms | Characteristic Lab Findings | CT Scan | Characteristic Histopathological Features |
---|---|---|---|---|
Insulinoma |
|
|
|
|
VIPoma |
|
|
|
|
Gastrinoma |
|
|
|
|
DDX 2
Characteristics | Insulinoma | Vipoma | Gastrinoma |
---|---|---|---|
Symptoms | |||
Diaphoresis |
Present |
Absent |
Absent |
Watery diarrhea |
Absent |
Present |
Absent |
Heartburn |
Absent |
Absent |
Present |
Lab values | |||
Hypoglycemia |
Present |
Absent |
Absent |
Hypokalemia |
Absent |
Present |
Absent |
Hypergastrinemia |
Absent |
Absent |
Present |
Imaging | |||
CT Scan |
Calcification and hyperattenuation of the mass |
Hypervascularity with diffuse multiple metastatic nodulation |
Small hypoattenuating nodule ± calcification |
MRI |
T2-weighted, increased-signal intensity mass |
T1-weighted, decreased-signal-intensity masses |
T1-weighted, decreased-signal intensity masses |
Histopathology |
Solid or gyriform cellular patterns with amyloid deposition, absence of glands, and nesidioblastosis |
Solid sheets with uniform cuboidal cells, centrally located nuclei, and granular cytoplasm |
Lobular-trabecular pattern of gastrin positive tumor cells with infiltration of Brunner glands |